现代中医临床2024，Vol.31Issue(5)：50-53,4.DOI:10.3969/j.issn.2095-6606.2024.05.011
从"肾虚血瘀"论治多系统萎缩
Treatment of multiple system atrophy through the lens of kidney deficiency and blood stasis
摘要
Abstract
Multiple system atrophy is a chronic and sporadic neurodegenerative disease. Traditional Chinese Medicine (TCM) considers its core pathogenesis to be rooted in deficiency of the liver,spleen,and kidney,with qi,blood,and fluid transportation and transformation imbalance as secondary characteristics. Clinical approaches often focus on treating liver and kidney deficiency,spleen and kidney deficiency,and the mutual obstruction of phlegm and blood stasis. Kidney deficiency and blood stasis are central pathogenic factors in multiple system atrophy. Kidney deficiency persists throughout the disease course and is crucial for treatment. Chronic progression of the disease involves blood stasis as both a pathological manifestation and a causative factor. As a chronic progressive disease,multiple system atrophy consistently presents patterns of deficiency and excess. Clinical treatment strategies emphasize addressing both symptoms and underlying causes,specifically through kidney supplementation and blood circulation promotion. Liuwei Dihuang Decoction (Six Ingredients Rehmannia Decoction) strengthens the kidneys and consolidates the foundation,while Siwu Decoction (Four Substances Decoction) promotes blood circulation and dispels stasis,effectively improving language and limb functions in multiple system atrophy patients. This paper discusses treating multiple system atrophy through the lens of kidney deficiency and blood stasis,supported by clinical cases.关键词
多系统萎缩/肾虚血瘀/补肾活血Key words
multiple system atrophy/kidney deficiency and blood stasis/supplementing the kidney and promoting blood circulation分类
医药卫生引用本文复制引用
黄香香,许红,柴利香,张晨晖,袁有才..从"肾虚血瘀"论治多系统萎缩[J].现代中医临床,2024,31(5):50-53,4.基金项目
陕西省自然科学基础研究计划项目(No.2022JM-470,2021JM-483) （No.2022JM-470,2021JM-483）
咸阳市中医药科研项目(No.2023-113-1) （No.2023-113-1）
陕西中医药大学研究生质量提升工程专项项目(No.CXSJ202323) （No.CXSJ202323）
